Volumetry is crucial in oncology and endocrinology, for diagnosis, treatment planning, and
evaluating response to therapy for several diseases. The integration of Artificial Intelligence …

Driven by the intricacy of the illness and the need for individualized treatments, targeted
therapy and biomarker research in thyroid cancer represent an important frontier in …

Precise dosimetry has gained interest for interpreting the response assessments of novel
therapeutic radiopharmaceuticals, as well as for improving conventional radiotherapies such …

Thyroid cancer, specifically differentiated thyroid carcinoma (DTC), is one of the most
prevalent endocrine malignancies worldwide. Radioactive iodine therapy (RAIT) using I-131 …

Theranostics refers to the combination of diagnostic biomarkers with therapeutic agents that
share a specific target expressed by diseased cells and tissues. Nuclear medicine is an …

Thyroid cancer is the fifth most prevalent cancer in women and the fastest-growing
malignancy. Although surgery is still the basis of treatment, internal radiation therapy …

Background: In 131I therapies internal dosimetry is crucial for determining the mean
absorbed dose to organs at risk, particularly the bone marrow, which has a dose constraint …

Simple Summary Thyroid carcinoma is the most common cancer of the endocrine system
and accounts for 12% of all cancer cases in adolescents in the United States. In this paper …

Although radioiodine for the treatment of differentiated thyroid cancer is most commonly
given as a fixed, empirical activity, it is well recognised that this leads to a wide range of …

Radioiodine (I-131) therapy is routinely used to treat conditions of the thyroid. Dosimetry
planning in advance of I-131 therapy has been shown to improve patient treatment …